Shanghai RAAS Blood Products Co., Ltd.
002252
Rang in aandelen
#3633
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aandeelprijs
$0.70717976
Marktkapitalisatie
$4.66B
Verandering (1 dag)
-0.20%
Verandering (1 jaar)
-24.51%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Categorie
Healthcare
EPS voor Shanghai RAAS Blood Products Co., Ltd. (002252)
EPS per June 2026 TTM: $0.03
Volgens de laatste financiële rapporten en de aandelenkoers van Shanghai RAAS Blood Products Co., Ltd. is de huidige EPS van het bedrijf (TTM) $0.03. Eind 2023 had het bedrijf een EPS van $0.04, gelijk aan de EPS van 2022 die $0.04 bedroeg.
EPS-geschiedenis van Shanghai RAAS Blood Products Co., Ltd. van 2005 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.03 | -47.80% |
| 2024 | $0.05 | 18.64% |
| 2023 | $0.04 | -6.16% |
| 2022 | $0.04 | 34.44% |
| 2021 | $0.03 | 0.33% |
| 2020 | $0.03 | 75.00% |
| 2019 | $0.02 | -138.14% |
| 2018 | $-0.05 | -272.80% |
| 2017 | $0.03 | -45.05% |
| 2016 | $0.05 | 6.26% |
| 2015 | $0.04 | 130.41% |
| 2014 | $0.02 | 203.13% |
| 2013 | $0.01 | -37.25% |
| 2012 | $0.01 | 12.09% |
| 2011 | $0.01 | 13.75% |
| 2010 | $0.01 | 40.35% |
| 2009 | $0.01 | 14.00% |
| 2008 | $0.01 | 19.05% |
| 2007 | 0.00 | -38.24% |
| 2006 | $0.01 | 3.03% |
| 2005 | $0.01 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | 66,260.15% |
US
|
|
| $-7.98 | -30,674.71% |
US
|
|
| $-5.29 | -20,368.20% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 106,183.52% |
NL
|
